Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography
1Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
2Department of Obstetrics and Gynecology, College of Medicine, Korea University, Seoul, South Korea
3Department of Nuclear Medicine, College of Medicine, Korea University, Seoul, South Korea
*Corresponding Author(s): S.H. Song E-mail: cooljog@dreamwiz.com
Background: 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) adds to conventional imaging in the detection and staging of peritoneal carcinomatosis. Case report: Herein we report a 27-year-old woman with multiple intraperitoneal masses detected by 18F-FDG-PET, suggesting peritoneal carcinomatosis. She had undergone laparoscopic unilateral oophorectomy for a left ovarian mucinous borderline tumor approximately five years before. Based on imaging and intraoperative findings, multiple intraabdominal masses strongly suggested peritoneal recurrence from a previous ovarian borderline tumor, but it finally proved to be inflammation and fibrosis on histopathologic examination. Conclusion: Although 18F-FDG-PET is well known to be a highly sensitive imaging tool for identification of peritoneal carcinomatosis, FDG uptake is not tumor-specific. Therefore, the possibility of a false-positive diagnosis due to benign conditions, such as inflammation, should always be taken into consideration.
Peritoneal carcinomatosis; 18F-fluorodeoxyglucose-positron emission tomography; Fibrosis; Inflammation
J.H. Hong,S.H. Song,S.E. Kim,J.K. Lee,N.W. Lee,K.W. Lee. Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography. European Journal of Gynaecological Oncology. 2011. 32(2);231-233.
[1] Juweid M.E., Cheson B.D.: “Positron-emission tomography and assessment of cancer therapy”. N. Eng. J. Med., 2006, 354, 496.
[2] Lenhard M.S., Mitterer S., Kumper C., Stieber P., Mayr D., Ditsch N. et al.: “Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2009, 145, 189.
[3] DeGaetano A.M., Calcagni M.L., Rufini V., Valenza V., Giordano A., Bonomo L.: “Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls”. Abdom. Imaging., 2009, 34, 391.
[4] Kim J.H., Kim G.E., Choi Y.D., Lee J.S., Lee J.H., Nam J.H. et al.: “Immunocytochemical panel for distinguishing between adenocarcinoma and reactive mesothelial cells in effusion cell blocks”. Diagn. Cytopathol., 2009, 37, 258.
[5] Iwasa Y., Minamiguchi S., Konishi I., Onodera H., Zhou J., Yamabe H.: “Sclerosing peritonitis associated with lutenized thecoma of the ovary”. Pathol. Int., 1996, 46, 510.
Top